|1.||Belcaro, G: 11 articles (04/2015 - 10/2001)|
|2.||Cesarone, M R: 10 articles (04/2015 - 10/2001)|
|3.||Incandela, L: 8 articles (10/2001 - 10/2001)|
|4.||De Sanctis, M T: 8 articles (10/2001 - 10/2001)|
|5.||Ippolito, E: 6 articles (04/2015 - 10/2001)|
|6.||Cacchio, M: 6 articles (10/2001 - 10/2001)|
|7.||Bucci, M: 6 articles (10/2001 - 10/2001)|
|8.||Griffin, M: 5 articles (10/2001 - 10/2001)|
|9.||Dugall, M: 4 articles (04/2015 - 10/2001)|
|10.||Cornelli, U: 3 articles (04/2015 - 09/2011)|
10/01/2001 - "The aim of this prospective, randomized study was to demonstrate whether an oral preparation of TTFCA was effective in improving the microcirculation and edema (leg volume) in venous microangiopathy. "
12/01/1991 - "[Efficacy of TTFCA in reducing the ratio between lymphatic and plasma protein concentration in lymphatic and postphlebitic edema]."
10/01/2001 - "The aim of this study was the evaluation of microcirculatory alterations associated with edema in passengers travelling for more than 3 hours and the study of the effects of TTFCA (total triterpenic fraction of Centella asiatica) on the development of microcirculation alterations and edema, in a prospective, randomized study. "
10/01/2001 - "RAS and edema were significantly lower in the TTFCA-treated group (p<0.025). "
10/01/2001 - "The effects of TTFCA on flux, RAS, and edema are important in early stages of microangiopathy to avoid progression to clinical stages."
|2.||Hypertension (High Blood Pressure)
10/01/2001 - "The aim of this study was to demonstrate whether total triterpenic fraction of Centella asiatica (TTFCA), was effective in improving the microcirculation in venous hypertension and microangiopathy. "
10/01/2001 - "Total triterpenic fraction of Centella asiatica (TTFCA) is effective in improving venous wall alterations in chronic venous hypertension and in protecting the venous endothelium. "
10/01/2001 - "In conclusion, TTFCA improves microcirculation and leg volume in venous hypertension. "
06/01/1994 - "Acute effects of TTFCA on capillary filtration in severe venous hypertension."
07/01/1990 - "In conclusion this study showed a combined improvement of the microcirculation and capillary permeability after treatment with TTFCA and the possibility of using the VSC to evaluate the effects of drugs (or other treatment) on local capillary permeability in patients with venous hypertension."
04/01/2015 - "The results justify a large, randomized, controlled study to demonstrate the efficacy of the combined Pycnogenol® and TTFCA prophylactic therapy in preclinical atherosclerosis."
04/01/2015 - "The aim of the study was to evaluate the effect of the nutritional supplements Pycnogenol® and total triterpenic fraction of Centella asiatica (TTFCA) on atherosclerosis progression in low-risk asymptomatic subjects with carotid or femoral stenosing plaques. "
02/01/2014 - "The results justify a large randomized controlled study to demonstrate the efficacy of the combined Pycnogenol and TECA prophylactic therapy in subclinical atherosclerosis."
02/01/2014 - "The aim of the study was to evaluate the effect of the nutritional supplements Pycnogenol and TECA (total triterpenic fraction of Centella Asiatica) on atherosclerosis progression in low-risk asymptomatic subjects with carotid or femoral non-stenosing plaques. "
|4.||Diabetic Angiopathies (Diabetic Angiopathy)
10/01/2001 - "Also TTFCA protects against the deterioration of microcirculation due to diabetic microangiopathy."
10/01/2001 - "According to these data, TTFCA is useful in diabetic microangiopathy by improving microcirculation and decreasing capillary permeability. "
10/01/2001 - "TTFCA is active on the microcirculation in venous and diabetic microangiopathy. "
10/01/2001 - "The aim of this study was to demonstrate in a prospective, placebo-controlled, randomized study, whether total triterpenic fraction of Centella asiatica (TTFCA) is effective in improving the microcirculation in diabetic microangiopathy and neuropathy, Patients with severe diabetic microangiopathy, neuropathy, and edema; patients with microangiopathy without neuropathy; and healthy subjects were included. "
01/01/2016 - "Surgery by means of partial or total ear canal ablation (PECA or TECA) combined with lateral bulla osteotomy (LBO) represents a feasible approach that is well tolerated and provides a good clinical outcome. "
09/01/2005 - "To evaluate differences in bacterial numbers, identity, and susceptibility in samples obtained from the tympanic cavity on entry (preflush) and after evacuation and lavage (postflush) and assess perioperative and empiric antimicrobial selection in dogs that underwent total ear canal ablation (TECA) with lateral bulla osteotomy (LBO) or reoperation LBO. "
05/01/2001 - "Drainage, by creating a separate opening for the horizontal ear canal, or total ear canal ablation and lateral bulla osteotomy (TECA/LBO), have led to resolution of the clinical signs. "
01/01/1995 - "Experimental total ear canal ablation with lateral tympanic bulla osteotomy (TECA-LBO) was performed in 13 normal dogs to evaluate healing and retention of brain stem auditory evoked potentials (BSAEP) after surgery. "
07/01/2012 - "This report describes a French bulldog and a pug that presented to the authors' hospital following total ear canal ablation (TECA) and lateral bulla osteotomy (LBO), with signs of recurring otitis media and difficulty opening their mouths. "
|6.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|7.||Propylene Glycol (1,2 Propanediol)
|9.||Stainless Steel (Steel, Stainless)
|10.||Dosage Forms (Dosage Form)
|4.||Artificial Liver (Bioartificial Liver)